2012 LigB-like
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Benzenoids | 4 | 0.7 | 6.17× | not tested | |
| Homogeneous metal compounds | 8 | 4.4 | 1.84× | not tested | |
| Homogeneous non-metal compounds | 2 | 1.9 | 1.05× | not tested | |
| Organoheterocyclic compounds | 1 | 1.4 | 0.73× | not tested | |
| Organic acids and derivatives | 1 | 1.4 | 0.73× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00143 | GSH | Glutathione | 8 |
| DB03946 | DHB | 3,4-Dihydroxybenzoic Acid | 3 |
| DB03407 | 4NC | 4-Nitrocatechol | 2 |
| DB14522 | OH | Hydroxide ion | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| FE2metal | FE (II) ION | 35 |
| FEmetal | FE (III) ION | 14 |
| A1EG2 | 3-[2,3-bis(oxidanyl)phenyl]propanoic acid | 10 |
| GDE | 3,4,5-trihydroxybenzoic acid | 8 |
| GSH | Glutathione | 8 |
| ZNmetal | ZINC ION | 5 |
| CU1metal | COPPER (I) ION | 4 |
| NAmetal | SODIUM ION | 4 |
| DHB | 3,4-DIHYDROXYBENZOIC ACID | 3 |
| 2AF | 2-AMINOPHENOL | 2 |
| 4NC | 4-NITROCATECHOL | 2 |
| 2X7 | (3E)-3-iminooxepin-2(3H)-one | 1 |
| 2XP | (2Z,4Z)-2-imino-6-oxohex-4-enoic acid | 1 |
| CL | CHLORIDE ION | 1 |
| OH | HYDROXIDE ION | 1 |